Do procalcitonin and C-reactive protein levels have a place in the diagnosis and follow-up of Helicobacter pylori infections?
|
|
- Katherine Bennett
- 5 years ago
- Views:
Transcription
1 Journal of Medical Microbiology (2004), 53, DOI /jmm Do procalcitonin and C-reactive protein levels have a place in the diagnosis and follow-up of Helicobacter pylori infections? Suat Saribas, 1 Bekir Kocazeybek, 1 Mustafa Aslan, 1 Sibel Altun, 1 Yalcın Seyhun, 2 Y. Ali Öner 3 and Nejat Memisoglu 4 Correspondence Bekir Kocazeybek bekirkcz@superonline.com 1 University of Istanbul, Cerrahpasa Faculty of Medicine, Department of Microbiology and Clinical Microbiology, Istanbul, Turkey 2,3 University of Istanbul, Istanbul Medical Faculty, Medical Biology Department 2 and Department of Microbiology and Clinical Microbiology 3, Istanbul, Turkey 4 Metropolitan Florence Nightingale Hospital, Gastroenterology Department, Istanbul, Turkey Received 29 July 2003 Accepted 5 April 2004 The aims of this study were to determine the levels of procalcitonin (PCT) and C-reactive protein (CRP) in Helicobacter pylori-positive (HP þ ) patients diagnosed with duodenal and gastric ulcer and to evaluate the correlation of PCT and CRP levels with other invasive and non-invasive diagnostic methods for determination of H. pylori eradication in post-treatment follow-up. Thirty-five HP þ patients with dyspepsia were included in this study. Serum samples (5 ml) were collected at admission and after 24 h. Antimicrobial therapy (omeprazole, amoxycillin and clarithromycin) was given for 1 week to HP þ patients who were positive only by culture or by urease test plus pathology. After 1 month, serum samples (5 ml) were collected again and culture, urease and pathology investigations were performed on endoscopic samples. PCT and CRP levels were measured in the collected blood samples. Thirty-five H. pylori-negative (HP ) cases with dyspepsia, 38 cases with bacteraemia and 35 healthy blood donors were included in this study as control groups. The mean and minimum maximum levels of PCT were ( ), ( ), ( ) and ( ) ng ml 1 for the groups of HP þ,hp and bacteraemia patients and healthy donors, respectively. Mean CRP levels were 1.00 (, ), 0.62 (, ), 11.5 ( ) and (, ) mg dl 1 for the same groups. A statistically significant difference was found between HP þ patients and both HP cases and healthy blood donors for PCT levels, and higher PCT levels were found on admission in cases of bacteraemia than in the other groups (P, 0. 05). PCT levels of HP þ cases decreased significantly (from to 0. 86) between admission and the post-treatment period (30 days); however, PCT levels remained higher than the cut-off value (0.5 ngml 1 ). Similar ranges of CRP levels were found over the same time-period. The sensitivity of PCT was found to be higher than that of CRP on admission, but the specificity of PCT was found to be lower than that of CRP on the day of admission (65 and 74 %, respectively). The sensitivity of PCT was the same as that of CRP for the post-treatment period, but specificity of PCT was higher than that of CRP for the post-treatment period (83 and 76 %, respectively). It was concluded that PCT and CRP are not very effective markers for H. pylori infection in primary diagnosis or in eradication follow-up after therapy when used in parallel with conventional diagnostic methods, even if there is a difference in PCT and CRP levels between HP þ and HP cases on admission. INTRODUCTION Helicobacter pylori has an important role inthe pathogenesis of Abbreviations: CRP, C-reactive protein; HP þ, H. pylori-positive; HP, H. pylori-negative; NPV, negative predictive value; PCT, procalcitonin; PPV, positive predictive value. peptic ulcer disease, and can also have a role in the development of mucosa-associated lymphoid tissue lymphoma and gastric cancer (IARC Working Group, 1994). Invasive diagnostic methods (which require endoscopy) and non-invasive diagnostic methods (which do not) are available for the diagnosis of H. pylori infections. Each test has its own advantages in relation to convenience in use, sensitivity and & 2004 SGM Printed in Great Britain IP:
2 S. Saribas and others specificity. For example, the urea breath-test is used for posttreatment follow-up (Logan, 1996) and studies of the detectionofh.pyloristoolantigenareofinterest(vairaetal.,1999). C-reactive protein (CRP) is an acute-phase reactant that originates from the liver. CRP has many clinical and biological effects and can be used for the diagnosis and follow-up of different inflammatory and traumatic processes (Le Moullec et al., 1984). Procalcitonin (PCT), a prohormone of calcitonin, is a polypeptide that consists of 116 aa and is released from the C cells in the thyroid gland of normal hosts during bacterial infections, particularly in sepsis. PCT is therefore useful for determining the diagnosis and prognosis of bacterial infections (Assicot et al., 1993). The aim of this study was to determine the diagnostic value of PCT and CRP and their benefits in the eradication and posttreatment follow-up of H. pylori infections by comparing PCT and CRP levels in patients diagnosed with duodenal and gastric ulcer with clinical findings and laboratory results in gastroenterology clinics. METHODS Patient and control groups Eighty patients (53 males and 27 females, aged 23 86) with dyspepsia, who attended gastroenterology clinics of two medical centres and were diagnosed with chronic gastritis and duodenal ulcer (by using four biopsy specimens taken from the antrum and corpus for the detection of H. pylori), were included in this study. Patients who had been treated with antibiotics during the 30 days preceding endoscopy or with bismuth compounds or proton pump inhibitors during the 4 months preceding endoscopy were excluded. Additional exclusion criteria were pregnancy or lactation, severe systemic illness, manifest clotting disorders or use of anticoagulants. Antimicrobial therapy (omeprazole, amoxycillin and clarithromycin) was given for 1 week to HP þ patients (n ¼ 40), who were determined to be H. pylori-positive by culture only or by urease test plus pathology. After 1 month, serum samples (5 ml) of 35 HP þ patients were collected again and culture, urease and pathology investigations were performed on endoscopic samples. The other five HP þ patients were not followed-up after therapy and were excluded from the study. Thirty-five HP patients out of 80 patients with dyspepsia, 38 patients with bacteraemia and 35 healthy blood donors were used as control groups. HP cases. H. pylori was judged to be present if culture only or histology plus culture were positive (Working Party of the European Helicobacter pylori Study Group, 1997). HP 2 cases. These cases were those that did not meet the diagnostic criteria of H. pylori by culture, urease test or histology. Cases with bacteraemia. Cases were defined as having true bacteraemia according to the criteria of Aranson & Bor (1987): growth in one culture or growth of a different micro-organism in one culture, contamination, growth of the same micro-organism in two of three consecutive cultures, real positivity. They were hospitalized with openheart surgery in the intensive-care unit (surgical) of the Cardiology Institute or in one of the centres in this study. Healthy blood donors. These were blood donors who had no gastric or duodenal symptoms and did not take any drugs related to these symptoms. Aetiology of duodenal and gastric ulcer (H. pylori diagnosis) Culture. Biopsy samples were inoculated on selective Columbia agar (Oxoid) plates, supplemented with sterile horse blood, vancomycin, nalidixic acid and trimethoprim and on non-selective blood and endo agar (Becton Dickinson). Plates were incubated at 37 8C in a microaerophilic atmosphere for 7 days. Identification was established by testing characteristic colonies for catalase, oxidase and urease production and Gram-stain morphology. Histopathology. Staining with haematoxylin and eosin was performed routinely for histopathological diagnosis and biopsy samples were reviewed according to the Sydney classification by a single pathologist. Urease test in tissue. A urease test kit (Pronto Dry) was used for the detection of urease activation caused by H. pylori from biopsy samples. A yellow colour that turned to red within 5 min indicated urease positivity. If the result was negative, the test was reassessed after 24 h. Collection of blood samples and analytical methods Serum samples (5 ml) were collected from 80 patients who complained of dyspeptic symptoms on admission and 24 h after admission. Serum samples (5 ml) were collected from 35 of 40 HP þ patients who were followed-up for 1 month after therapy with invasive test procedures, including endoscopy. Serum samples from 35 HP cases were collected only on admission and 24 h after admission. Blood samples of the 38 patients with bacteraemia were collected when definite diagnoses were made from clinical findings and laboratory results. Blood samples (with no anticoagulants) of 35 healthy blood donors were collected on admission. Serum samples were stored in the laboratory at 70 8C until the test was performed. For detection of PCT levels in serum, a monoclonal, immunoluminometric method (Lumitest PCT; BRAHMS Diagnostica) was used. In this method, which is specific to the PCT molecule, two different mabs that bind to calcitonin and catacalcin are used. This test can detect levels as low as 0.1ngml 1, considering that internal evaluation levels are between 0.1 and 500 ng ml 1. The pathological limit is evaluated as >0. 5ngml 1 ; this value is, 0.5 ngml 1 for healthy people (Meisner, 1996). For detection of CRP levels in serum, an immunoturbidimetric analyser (BIA; Behring Diagnostics) was utilized and a concentration of >0.5 mgdl 1 was evaluated as a pathological value (Behring Diagnostics, 1997). A Mann Whitney U-test was used in the comparison of the evaluation of PCT and CRP values between patient and control groups on admission, by statistical analysis using the program STATE 5.0. RESULTS On endoscopy, 57 patients showed normal mucosa, 11 had active or scarred gastric or duodenal ulcer and 12 had gastric and duodenal erosions. H. pylori was detected in 40 of 80 cases by culture only or by urease test and histology. Forty cases were determined to be HP. Thirty-five HP þ and 35 HP cases (out of the total of 80) were included in this study. The remaining HP þ (5) and HP (5) cases were excluded. The PCT levels of 35 HP þ cases on admission, given as mean (minimum maximum), were ( ) ng ml 1. The PCT levels of HP cases on admission were ( ) ng ml 1. The PCT levels of patients with bacteraemia and healthy blood donors on admission were ( ) and ( ) ng ml 1, respectively. The CRP levels of HP þ cases, HP cases, patients with bacteraemia and healthy blood donors on admission were (, ), (, ), 11. 5( ) and (, ) mg dl 1, respectively. A significant difference 640 IP: Journal of Medical Microbiology 53
3 Procalcitonin and CRP levels in H. pylori infection (P, 0. 05) was detected between the PCT levels of HP þ cases on admission, compared to HP cases and healthy blood donors. When PCT and CRP levels were compared in HP þ and bacteraemia patients, values in patients with bacteraemia were much higher than those in HP þ cases (P, 0. 05). No significant difference (P ) was detected between the other groups. The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of PCT were 57, 65, 76 and 66 %, respectively, on admission. The same parameters for CRP on admission were 30, 74, 75 and 44 %, respectively. The sensitivity, specificity, PPV and NPV of PCT and CRP (evaluated together) were 50, 60, 62 and 55 %, respectively. The same parameters were 60, 70, 72 and 75 %, respectively, when the two parameters were evaluated separately. PCT levels of HP þ cases increased slightly during the 24 h following admission, but decreased significantly after therapy. However, they remained higher than the cut-off value (0. 5ngml 1 ). Approximate CRP levels in each of the three periods (admission, after 24 h and post-therapy) were 1. 00, and mg dl 1 (Table 1, Fig. 1). Five HP þ cases continued to be positive, according to invasive diagnostic methods, after therapy. The sensitivity, specificity, PPV and NPV of PCT were 60, 83, 62 and 92 %, respectively, after therapy and the same parameters for CRP were 60, 76, 30 and 92 %, respectively (Table 2). DISCUSSION There has been interest in using PCT as a highly efficient, easy-to-use, less expensive marker for diagnostic and prognostic purposes in various bacterial infections, particularly in septicaemia, as evidenced by the growing number of publications (Gramm et al., 1995; Ugarte et al., 1999; Kocazeybek et al., 2003). The amount of PCT induced depends on the Fig. 1. Mean serum values of procalcitonin and C-reactive protein in H. pylori infections over time. j, PCT (ng ml 1 ); r, CRP (mg dl 1 ). infected organ, whether invasion is systemic or localized and the extent of inflammation. PCT levels can be as high as 1000 ng ml 1 in septicaemia and can decrease to,5 ngml 1 in localized and viral infections, as well as in non-infectious inflammation. CRP, an acute-phase reactant, increases during any inflammatory period, whether it is infectious or traumatic. It is also detected in high concentrations in cases where no bacterial infections exist. High concentrations of CRP were also found in polytraumatic cases. CRP levels remain high after recovery (Gramm et al., 1995; Ugarte et al., 1999; Kocazeybek et al., 2003). In this study, the serum levels of PCT and CRP in HP þ patients were found to be ng ml 1 and mg dl 1, respectively, on their admission to hospital. The PCT and CRP levels in serum obtained from these patients increased slightly over 24 h. However, PCT and CRP levels in serum obtained from HP patients were lower than those in HP þ cases. There was a significant difference between HP þ and HP cases in PCT levels, Table 1. PCT and CRP levels of patient and control groups PCT sensitivity for H. pylori diagnosis on admission, 57 %; specificity, 65 %; PPV, 76 %; NPV, 66 %. CRP parameters: 30, 74, 75 and 44 %, respectively. Abbreviations: min, minimum; max, maximum. Patient and control groups (n) Time of blood sample Mean [PCT] (min max) (ng ml 21 ) Mean [CRP] (min max) (mg dl 21 ) HP þ (35) Admission ( ) (, ) 24 h ( ) (, ) AT* ( ) (, ) HP (35) Admission ( ) (, ) 24 h 0.38 ( ) 0.59 (, ) Cases with bacteraemia (38) On diagnosis 7.45 ( ) 11.5 ( ) Healthy group (35) On admission 0.40 ( ) 0.63 (, ) Significance testing: HP þ 3 H P, 0.05 P Bacteraemia 3 HP þ P, 0.05 P, 0.05 HP þ 3 Healthy group P, 0.05 P *AT, 30 days (after 1 week therapy). IP:
4 S. Saribas and others Table 2. H. pylori-positive and -negative cases after therapy Five positive cases were detected after therapy, according to the criteria for diagnosis of H. pylori. The pathological borderline was taken to be 0.5mgdl 1. Cut-off value HP HP 2 Sensitivity (%) Specificity (%) PPV (%) NPV (%) PCT: > , CRP: > , whereas no significant difference in CRP levels was detected between HP þ and HP cases. There was also a significant difference in PCT levels between healthy blood donors and HP þ cases. Similarly, a significant difference was also found in PCT levels between the healthy control group and HP þ cases. Gastric and duodenal infection with H. pylori invasion gives a local organ pathology that originates from urease, cytotoxins, adhesins, heat-shock proteins, gastric immune response and environmental conditions (D Elios et al., 1998). To date, no study has reported PCT and CRP levels in acute or generally chronic, non-bacteraemic clinical cases. Gendrel & Bohuon (2000) have shown that, in serial studies, serum PCT levels were lower in localized bacterial infections with negative blood cultures than in systemic bacterial infections with positive blood cultures. A study from France has demonstrated that a cut-off value of 1 ng ml 1 was detectable in localized infections. This was a useful parameter for indicating the severity of infection (Gendrel et al., 1999). A similar result was also reported by investigators from Czechoslovakia (Jarešová et al., 1999). Soderquist et al. (1998) have shown that PCT was detectable in moderate levels in cases with closed, focused infections, such as infectious arthritis in adults. Kocazeybek et al. (2003) reported that PCT levels were and ng ml 1 in two out of 40 infective endocarditis cases, whereas PCT levels averaged ng ml 1 in a non-infective endocarditis control group. Several reports have indicated that PCT levels vary between 0. 5 and 2 ng ml 1 in localized, non-bacteraemic, bacterial infections in adults and children (Soderquist et al., 1998; Gendrel et al., 1999; Jarešová et al., 1999). PCT levels in serum from acute or chronic cases of H. pylori infection and cases of local organ invasion are in accord with the results of other studies. Conversely, CRP, which is considered to be a marker of acute, systemic inflammation, can be detected at a slightly higher level than the cut-off value in H. pylori infections; this is responsible for localized tissue damage. Therefore, we think that this result can be related to the suggestion that elevated CRP levels are proportional to the extent of tissue damage in general. However, Choussat et al. (2000) suggested that markers of inflammation, such as CRP, were not sufficient to detect infection after a study that determined a correlation between chronic H. pylori infection and coronary heart disease. These authors also emphasized that the characteristics of the micro-organism play an important role in inflammation that originates from chronic infection. In fact, unlike other Gram-negative bacteria (such as Escherichia coli and Salmonella), lipid A molecules in H. pylori strains do not have phosphate groups and they carry four-carbon fatty acids instead of six-carbon ones, increasing the number of carbon atoms. These differences cause a weak induction in proinflammatory cytokine release, particularly IL6 and IL8 from monocytes and neutrophils (Crabtree et al., 1994; Moran, 1998; Strömberg et al., 2003). Althought PCT and CRP differ in terms of their release mechanisms from organelles, biosynthesis and stability in serum, their levels were detected to be low (near the cut-off value) in HP þ cases on admission. This result can be related to some known factors (such as characteristics of LPS in the H. pylori cell wall, the level of immune response in the gastroduodenal region and local characteristics of inflammation) and some other, currently unknown factors that may have a role in the bacteria host relationship. PCT sensitivity and specificity of dyspeptic HP þ cases were higher and lower, respectively, than CRP sensitivity and specificity, on the basis of 0. 5 cut-off value for each of the two markers. Our results differ from those of other studies, which demonstrated higher specificity and lower sensitivity for PCT than for CRP (Assicot et al., 1993; Ugarte et al., 1999; Lorrot et al., 2000; Blijlevens et al., 2000). In our study, sensitivity and specificity rose slightly when we considered the two indicators together (PCT and CRP) and decreased when we considered them separately in the diagnosis of H. pylori infections of dyspeptic patients. However, Ugarte et al. (1999) suggested that specificity was raised when PCT and CRP were considered together in prediagnosis of bacterial infections of patients that were hospitalized in intensive-care units. In a similar study, Rothenburger et al. (1999) suggested that specificity was particularly raised when PCT and CRP were considered together in the determination of local and systemic infections after cardiac surgery in Germany. Kocazeybek et al. (2003) suggested that sensitivity and specificity for the diagnosis of infective endocarditis were raised when PCT and CRP were considered separately in a study of 50 patients with infective endocarditis. Tunçbilek et al. (2000) suggested that sensitivity and specificity were raised when PCT and CRP were considered separately in 642 IP: Journal of Medical Microbiology 53
5 Procalcitonin and CRP levels in H. pylori infection the diagnosis of 33 patients with serious bacterial infections and sepsis. Our results were in concordance with the results of Kocazeybek et al. (2003) and Tunçbilek et al. (2000); however, they were different from those reported by Ugarte et al. (1999) and Rothenburger et al. (1999). The mean PCT level was detected to be higher than the cutoff value of 0.5 ngml 1 ; even so, the mean PCT level of HP þ cases after therapy decreased significantly when compared with PCT levels on admission. CRP levels on admission and after therapy were similar to each other. However, PCT declined to normal levels significantly faster than CRP in serious infections such as pneumonia, meningitis, pericarditis and infection-complicated cases after operation. It has been reported that this decrease in PCT levels can be an indicator of recovery. Conversely, CRP levels remained high during therapy and decreased gradually over a long period of time. In our study, PCT levels decreased with therapy, although they did not reach normal levels. There may be several reasons for this result. As we have detected in our work, it was thought that continuous PCT induction may occur in H. pylori-infected regions and this may be caused by the continuous presence of H. pylori in the infected regions, as a consequence of factors such as insufficient epithelial cytokine response in the gastroduodenal region and unresponsiveness to therapy in some cases (Vaira et al., 1999; Strömberg et al., 2003). In some severe, systemic bacterial infections, PCT levels decrease with clinical recovery (Gendrel et al., 2000). Conversely to this result, in our study, PCT levels were detected to be approximately equal to or slightly higher than the cut-off value in some HP cases after therapy. It is probable that PCT levels are still detected in serum at around the cut-off level, despite eradication after therapy. This observation may be related to specific characteristics of H. pylori infections (local, duration of chronic inflammation, development of an immunopathogenesis base as a result of interactions in the host immune response with H. pylori virulence factors) in the gastroduodenal region. It was concluded that PCT and CRP were not very effective markers for primary diagnosis, as well as eradication followup after therapy, when they were used in parallel with conventional diagnostic methods, even if there was difference in PCT levels as opposed to CRP levels between HP þ and HP cases on admission. REFERENCES Aranson, M. D. & Bor, D. H. (1987). Blood cultures. Ann Intern Med 106, Assicot, M., Gendrel, D., Carsin, H., Raymond, J., Guilbaud, J. & Bohuon, C. (1993). High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341, Behring Diagnostics (1997). Behring Turbitimer Instruction Manual, version T.T.30. Warburg: Behring Diagnostics. Blijlevens, N. M. A., Donnelly, J. P., Meis, J. F. G. M., De Keizer, M. H. & De Pauw, B. E. (2000). Procalcitonin does not discriminate infection from inflammation after allogeneic bone marrow transplantation. Clin Diagn Lab Immunol 7, Choussat, R., Montalescot, G., Collet, J.-P. & 10 other authors (2000). Effect of prior exposure to Chlamydia pneumoniae, Helicobacter pylori, or cytomegalovirus on the degree of inflammation and one-year prognosis of patients with unstable angina pectoris or non-q-wave acute myocardial infarction. Am J Cardiol 86, Crabtree, J. E., Perry, S. & Moran, A. (1994). Neutrophil IL-8 secretion induced by H. pylori. Am J Gastroenterol 89, D Elios, M. M., Andersen, L. P. & Del Prete, G. (1998). Inflammation and host response. Curr Opin Gastroenterol 14 (Suppl. 1), S15 S20. Gendrel, D. & Bohuon, C. (2000). Procalcitonin as a marker of bacterial infection. Pediatr Infect Dis J 19, Gendrel, D., Raymond, J., Coste, J. & 9 other authors (1999). Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentation of bacterial vs. viral infections. Pediatr Infect Dis J 18, Gramm, H.-J., Dollinger, P. & Beier, W. (1995). Procalcitonin ein neuer Marker der inflammatorischen Wirtsantwort. Longitudinalstudien bei Patienten mit Sepsis und Peritonitis. Chir Gastroenterol 11 (Suppl. 2), (in German). IARC Working Group (1994). Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the evaluation of carcinogenic risks to humans. Lyon, 7 14 June IARC Monogr Eval Carcinog Risks Hum 61, Jarešová, M., Střiž, I., Čermáková, J., Lácha, J., Sedláček, J., Mudra, K., Hána, I. & Vítko, Š. (1999). Serum procalcitonin concentrations in transplant patients with acute rejection and bacterial infections. Immunol Lett 69, Kocazeybek, B., Küçükoǧlu, S. & Öner, A. (2003). Procalcitonin and C- reactive protein in infective endocarditis: correlation with etiology and prognosis. Chemotherapy 49, Le Moullec, J. M., Jullienne, A., Chenais, J., Lasmoles, F., Guliana, J. M., Milhaud, G. & Moukhtar, M. S. (1984). The complete sequence of human preprocalcitonin. FEBS Lett 167, Logan, R. P. H. (1996). The C13 urea breath test. In Helicobacter pylori: Technique for Clinical Diagnosis and Basic Research, pp Edited by A. Lee & F. Megraud. Philadelphia: WB Saunders. Lorrot, M., Moulin, F., Coste, J. & 7 other authors (2000). Procalcitonin in pediatric emergencies: comparison with C-reactive protein, interleukin-6 and interpheron alpha in the differentiation between bacterial and viral infections. Presse Med 29, (in French). Meisner, M. (1996). PCT, procalcitonin a new, innovative marker for severe infection and sepsis. Biochemical and clinical aspects. Berlin: BRAHMS Diagnostica. Moran, A. (1998). The products of Helicobacter pylori that induce inflammation. Eur J Gastroenterol Hepatol 10 (Suppl. 1), S3 S8. Rothenburger, M., Markewitz, A., Lenz, T., Kaulbach, H. G., Marohl, K., Kuhlmann, W. D. & Weinhold, C. (1999). Detection of acute phase response and infection. The role of procalcitonin and C-reactive protein. Clin Chem Lab Med 37, Soderquist, B., Jones, I., Fredlund, H. & Vikerfors, J. (1998). Bacterial or crystal-associated arthritis? Discriminating ability of serum inflammatory markers. Scand J Infect Dis 30, Strömberg, E., Edebo, A., Svennerholm, A.-M. & Lindholm, C. (2003). Decreased epithelial cytokine responses in the duodenal mucosa of Helicobacter pylori-infected duodenal ulcer patients. Clin Diagn Lab Immunol 10, IP:
6 S. Saribas and others Tunçbilek, S., Baykam, N., Hızel, K. & Dokuzoǧaz, B. (2000). Farklı bakteriyel infeksiyonların tanısında prokalsitoninin rolü. Flora 5, (in Turkish). Ugarte, H., Silva, E., Mercan, D., De Mendonca, A. & Vincent, J.-L. (1999). Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 27, Vaira, D., Malfertheiner, P., Mégraud, F. & 8 other authors (1999). Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. Lancet 354, Working Party of the European Helicobacter pylori Study Group (1997). Technical annex: tests used to assess Helicobacter pylori infection. Gut 41 (Suppl. 2), S10 S IP: Journal of Medical Microbiology 53
Research paper 45. Address: Department of Anaesthesiology, University of Erlangen-Nuremburg, Krankenhausstr. 12, D Erlangan, Germany.
Research paper 45 Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS Michael Meisner, Klaus Tschaikowsky,
Helicobacter and gastritis
1 Helicobacter and gastritis Dr. Hala Al Daghistani Helicobacter pylori is a spiral-shaped gram-negative rod. H. pylori is associated with antral gastritis, duodenal (peptic) ulcer disease, gastric ulcers,
What is the status of Sequential Therapy Versus Standard Triple- Drug Therapy in peptic ulcer disease in eradicating H pylori?
What is the status of Sequential Therapy Versus Standard Triple- Drug Therapy in peptic ulcer disease in eradicating H pylori? Sequential Therapy Versus Standard Triple- Drug Therapy for Helicobacter pylori
Helicobacter pylori: Diagnosis, treatment and risks of untreated infection
Helicobacter pylori: Diagnosis, treatment and risks of untreated infection Klaus Mönkemüller Department of Gastroenterology, Hepatology und Infectius Diseases Otto-von-Guericke University, Magdeburg bb
The Nobel Prize in Physiology or Medicine for 2005
The Nobel Prize in Physiology or Medicine for 2005 jointly to Barry J. Marshall and J. Robin Warren for their discovery of "the bacterium Helicobacter pylori and its role in gastritis and peptic ulcer
Helicobacter pylori:an Emerging Pathogen
Bacteriology at UW-Madison Bacteriology 330 Home Page Helicobacter pylori:an Emerging Pathogen by Karrie Holston, Department of Bacteriology University of Wisconsin-Madison Description of Helicobacter
Research Article Performance of Routine Helicobacter pylori Invasive Tests in Patients with Dyspepsia
Gastroenterology Research and Practice Volume 2013, Article ID 184806, 5 pages http://dx.doi.org/10.1155/2013/184806 Research Article Performance of Routine Helicobacter pylori Invasive Tests in Patients
Helicobacter pylori Eradication Therapy Success Regarding Different Treatment Period Based on Clarithromycin or Metronidazole Triple-Therapy Regimens
Helicobacter ISSN 1523-5378 Filipec Blackwell Oxford, HEL 1083-4389 1523-5378 Journal XXX Original H. 2008 pylori Kanizaj compilation The UK Eradication Publishing Article Authors et al. Ltd 2008 Therapy
Utility of In House made Rapid Urease Broth Test for Detection of Helicobacter pylori Infection in Resource Constraint Settings
Original article: Utility of In House made Rapid Urease Broth Test for Detection of Helicobacter pylori Infection in Resource Constraint Settings 1.Dr. Swati Rahul Dhope, 2. Dr. Sachinkumar Vasantrao Wankhede
Helicobacter Pylori Testing HELICOBACTER PYLORI TESTING HS-131. Policy Number: HS-131. Original Effective Date: 9/17/2009
Easy Choice Health Plan, Inc. Harmony Health Plan of Illinois, Inc. Missouri Care, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance of Arizona, Inc. WellCare Health Insurance of Illinois,
Evaluation of a new rapid immunoassay for the detection of Helicobacter pylori in faeces: a prospective pilot study
Aliment Pharmacol Ther 2005; 21: 485 489. doi: 10.1111/j.1365-2036.2005.02355.x Evaluation of a new rapid immunoassay for the detection of Helicobacter pylori in faeces: a prospective pilot study L. TREVISANI*,
Disclosures. Co-founder and Chief Science Officer, TechLab
H. pylori testing Disclosures Co-founder and Chief Science Officer, TechLab Learning Objectives Evaluate the appropriate testing methodology by balancing performance, economics, and workflow. Discuss the
H. pylori Antigen ELISA Kit
H. pylori Antigen ELISA Kit Catalog Number KA3142 96 assays Version: 04 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle of
Helicobacter 2008;13:1-6. Am J Gastroent 2007;102: Am J of Med 2004;117:31-35.
An Update on Helicobacter pylori and Its Treatment Trenika Mitchell, PharmD, BCPS Clinical Assistant Professor University of Kentucky College of Pharmacy October 18, 2008 Objectives Review the epidemiology
Index. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Adherence, to bismuth quadruple therapy, 543 546 Adjuvant therapy, probiotics as, 567 569 Age factors, in gastric cancer, 611 612, 616 AID protein,
Correlation Between Endoscopic and Histological Findings in Different Gastroduodenal Lesion and its Association with Helicobacter Pylori
ORIGINAL ARTICLE Correlation Between Endoscopic and Histological Findings in Different Gastroduodenal Lesion and its Association with Helicobacter Pylori *A. Sultana 1, SM Badruddoza 2, F Rahman 3 1 Dr.
Fecoprevalence and determinants of Helicobacter pylor infection among asymptomatic children in Myanmar
International Journal of Gastroenterology, Hepatology, Transplant & Nutrition Original Article Fecoprevalence and determinants of Helicobacter pylor infection among asymptomatic children in Myanmar Hnin
Type of intervention Diagnosis. Economic study type Cost-effectiveness analysis.
Noninvasive tests as a substitute for histology in the diagnosis of Helicobacter pylori infection Hahn M, Fennerty M B, Corless C L, Magaret N, Lieberman D A, Faigel D O Record Status This is a critical
Serial serum procalcitonin changes in the prognosis of acute stroke
University of Wollongong Research Online Faculty of Science, Medicine and Health - Papers Faculty of Science, Medicine and Health 2004 Serial serum procalcitonin changes in the prognosis of acute stroke
Procalcitonin in children admitted to hospital with community acquired pneumonia
332 Pediatrics, Hôpital, 82 Av Denfert-Rochereau, 7514 Paris, France F Moulin M Lorrot E Marc J-L Iniguez D Gendrel Microbiology, Hôpital J Raymond Statistics, Hôpital Cochin/Saint Vincent de Paul J Coste
(Received September 12, Accepted April 23, 1997) Jpn. J. Med. Sci. Biol., 50, 55-62, 1997.
Jpn. J. Med. Sci. Biol., 50, 55-62, 1997. EVALUATION OF CULTURE, HISTOLOGICAL EXAMINATION, SEROLOGY AND THE RAPID UREASE TEST FOR DIAGNOSIS OF HELICOBACTER PYLORI IN PATIENTS WITH DYSPEPSIA IN BANGLADESH
Corporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: helicobacter_pylori_testing 01/01/2019 N/A 01/01/2020 01/01/2019 Policy Effective April 1, 2019 Description
Comparative study of invasive methods for diagnosis of Helicobacter pylori in humans
ISSN: 2319-7706 Volume 2 Number 7 (2013) pp. 63-68 http://www.ijcmas.com Original Research Article Comparative study of invasive methods for diagnosis of Helicobacter pylori in humans V.Subbukesavaraja
Urea Breath Test for Diagnosis of Helicobactor pylori. Original Policy Date 12:2013
MP 2.04.04 Urea Breath Test for Diagnosis of Helicobactor pylori Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date 12:2013 Return to Medical Policy Index
- Helicobacter - THE EASE AND DIFFICULTY OF A NEW DISCOVERY. Robin Warren
- Helicobacter - THE EASE AND DIFFICULTY OF A NEW DISCOVERY Robin Warren EARLY DAYS First reports 100 years ago considered spirochaetes 1940 Freedburg saw curved organisms in the stomach 1954 Palmer: Freedburg
Comparison of the Accuracy of Two Commercial Rapid Urase Tests, CLOtest and Pronto Dry, in Detecting Helicobacter pylori Infection ABSTRACT
Original Article Rojborwonwitaya J, Vijitjunyakul N THAI J GASTROENTEROL 2005 Vol. 6 No. 2 May - Aug. 2005 55 Comparison of the Accuracy of Two Commercial Rapid Urase Tests, CLOtest and Pronto Dry, in
COMPARISON OF ONCE-A-DAY VERSUS TWICE-A-DAY CLARITHROMYCIN IN TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION
Phil J Gastroenterol 2006; 2: 25-29 COMPARISON OF ONCE-A-DAY VERSUS TWICE-A-DAY CLARITHROMYCIN IN TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION Marianne P Collado, Ma Fatima P Calida, Peter P Sy,
Gilles Jequier. Commercial Director Organobalance, a Novozymes Company
"Latest clinical Evidences showing that a proprietary Lactobacillus reuteri Strain can reduce the Symptoms associated with a Helicobacter pylori Infection" Gilles Jequier Commercial Director Organobalance,
Helicobacter pylori 幽門螺旋桿菌 馬偕紀念醫院新竹分院一般內科, 肝膽腸胃科陳重助醫師
Helicobacter pylori 幽門螺旋桿菌 馬偕紀念醫院新竹分院一般內科, 肝膽腸胃科陳重助醫師 Hp : Helicobacter pylori Part 1. Pathophysiology and immune response Pathogenesis of Hp infection Part 2. Clinical manifestation Part 3. Dx tests for
TRANSPARENCY COMMITTEE OPINION. 13 December 2006
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 13 December 2006 HELIKIT 75 mg, powder for oral solution CIP : 343 132-1 Applicant : MAYOLY SPINDLER 13 Curea anhydrous
H. pylori IgM CLIA kit
H. pylori IgM CLIA kit Cat. No.:DEEL0251 Pkg.Size:96 tests Intended use Helicobacter pylori IgM Chemiluminescence ELISA is intended for use in evaluating the serologic status to H. pylori infection in
Acid-Peptic Diseases of the Stomach and Duodenum Including Helicobacter pylori and NSAIDs Prof. Sheila Crowe
Acid-Peptic Diseases of the Stomach and Duodenum Including Helicobacter pylori and NSAIDs 1 Division of Gastroenterology UC San Diego School of Medicine Clinical presentations of Helicobacter pylori infection
KEYWORDS Dyspepsia, Acid Peptic Disease, Helicobacter Pylori, Urease, Giemsa, Peptic Ulcer, Non-Ulcer Dyspepsia.
INCIDENCE OF HELICOBACTER PYLORI WITH ACID PEPTIC DISEASE AND MALIGNANT CONDITIONS OF UPPER GASTROINTESTINAL TRACT IN A TERTIARY CENTRE - A PROSPECTIVE STUDY Karunamoorthy Rajachidambaram 1, Dinkaran Kaarthesan
Gastric atrophy: use of OLGA staging system in practice
Gastroenterology and Hepatology From Bed to Bench. 2016 RIGLD, Research Institute for Gastroenterology and Liver Diseases ORIGINAL ARTICLE Gastric atrophy: use of OLGA staging system in practice Mahsa
L utilizzo della Procalcitonina in Medicina d Urgenza
L utilizzo della Procalcitonina in Medicina d Urgenza Stefania Battista Dirigente Medico S.C. Medicina d Urgenza Azienda Ospedaliero-Universitaria San Giovanni Battista di Torino Savona, 15 ottobre 2009
Helicobacter pylori resistance in the Netherlands: a growing problem?
ORIGINAL ARTICLE Helicobacter pylori resistance in the Netherlands: a growing problem? R. Ruiter 1,2 *, H.F. Wunderink 3, R.A. Veenendaal 5, L.G. Visser 4, M.G.J. de Boer 4 Departments of 1 Internal Medicine,
Campylobacter like organisms on the gastric mucosa:
J Clin Pathol 1984;37:1002-1006 Campylobacter like organisms on the gastric mucosa: culture, histological, and serological studies DM JONES,* AM LESSELLS,t JOAN ELDRIDGE* From the *Public Health Laboratory
The Pattern of Procalcitonin in Primary Total Hip and Knee Arthroplasty and its Implication in Periprosthetic Infection
Original Article The Pattern of Procalcitonin in Primary Total Hip and Knee Arthroplasty and its Implication in Periprosthetic Infection Syed Ali a, d, Andrew Christie b, Andrew Chapel c Abstract Background:
New immunoassay for the detection of Helicobacter pylori infection compared with urease test,
Chapter V New immunoassay for the detection of Helicobacter pylori infection compared with urease test, 13C breath test and histology: validation in the primary care setting Catherine F Weijnen 1, Henriëtte
Disclosures. Learning Objectives: Marker for Inflammation
39 th National Conference on Pediatric Health Care March 19-22, 2018 CHICAGO Inflammatory Markers: When and What to Order and What to Do With the Number None to disclose Disclosures Cathy S. Woodward,
Peptic Ulcer Disease Update
Peptic Ulcer Disease Update Col Pat Storms RAM 2005 Disclosure Information 84th Annual AsMA Scientific Meeting Col Patrick Storms I have no financial relationships to disclose. I will discuss the following
BIOMARKERS IN SEPSIS
BIOMARKERS IN SEPSIS Dr. Syed Ghulam Mogni Mowla Assistant Professor, Medicine, DMC BSMCON 17 WHY WE NEED TO KNOW Sepsis and its complications are a common cause of infectious disease illness and mortality
PDF hosted at the Radboud Repository of the Radboud University Nijmegen
PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/48400
Helicobacter Connections. Barry Marshall
Helicobacter Connections Barry Marshall The greatest obstacle to knowledge is not ignorance, it is the illusion of knowledge. Daniel Boorstein - Historian Peptic Ulcers Duodenal Ulcer (DU) Gastric Ulcer
Helicobacter pylori Improved Detection of Helicobacter pylori
DOI:http://dx.doi.org/10.7314/APJCP.2016.17.4.2099 RESEARCH ARTICLE Improved Detection of Helicobacter pylori Infection and Premalignant Gastric Mucosa Using Conventional White Light Source Gastroscopy
A Heaney, J S A Collins, RGPWatson, R J McFarland, K B Bamford, T C K Tham
186 Royal Victoria Hospital, Belfast, A Heaney J S A Collins Department of Medicine, Queen s University, Belfast, RGPWatson Ulster Hospital, Dundonald, R J McFarland T C K Tham Department of Microbiology
Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer
618 University Department of Medicine and Therapeutics, Western Infirmary, Glasgow G11 6NT, UK K E L McColl A El-Nujumi L S Murray E M El-Omar A Dickson A W Kelman T E Hilditch Correspondence to: Professor
H.Pylori IgG
DIAGNOSTIC AUTOMATION, INC. 21250 Califa Street, Suite 102 and116, Woodland Hills, CA 91367 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com
H.Pylori IgG Cat # 1503Z
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external
Associations between the Plasticity Region Genes of Helicobacter pylori and Gastroduodenal Diseases in a High-Prevalence Area
Gut and Liver, Vol. 4, No. 3, September 2010, pp. 345-350 original article Associations between the Plasticity Region Genes of Helicobacter pylori and Gastroduodenal Diseases in a High-Prevalence Area
594 Lewin, Weinstein, and Riddell s Gastrointestinal Pathology and Its Clinical Implications
594 Lewin, Weinstein, and Riddell s Gastrointestinal Pathology and Its Clinical Implications Figure 13-20. Stages in the natural history of H. pylori. Biopsies from the antrum are on the left and the oxyntic
Semi-quantitative Procalcitonin Test for the Diagnosis of Bacterial Infection: Clinical Use and Experience in Japan
Also available online http://www.e-jmii.com ISSN 1684-1182 Volume 43 Number 3 June 2010 Indexed in MEDLINE/Medicus, SCIE, BIOSIS, EMBASE, Aidsline, CancerLit, Chemical Abstracts, HealthSTAR The official
H. pylori IgM. Cat # H. pylori IgM ELISA. ELISA: Enzyme Linked Immunosorbent Assay. ELISA - Indirect; Antigen Coated Plate
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com H. pylori
Sensitivity to nitazoxanide among metronidazole resistant Helicobacter pylori strains in patients with gastritis
Original Article Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences Sensitivity to nitazoxanide among metronidazole resistant Helicobacter pylori strains in patients
See external label 2 C-8 C Σ=96 tests Cat # 1505Z. MICROWELL ELISA H.Pylori IgA Cat # 1505Z
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external
Dr Hamed Al-Zoubi Ass. Prof. / Medical Microbiology
Dr Hamed Al-Zoubi Ass. Prof. / Medical Microbiology PSEUDOMONAS BRUCELLA LEGIONELLA CAMPYLOBACTER HELICOBACTER PYLORI (H.PYLORI) Pseudomonas Pseudomonas aeruginosa, Burkholderia pseudomallei and Burkholderia
Dr Hamed Al-Zoubi Ass. Prof. / Medical Microbiology
Dr Hamed Al-Zoubi Ass. Prof. / Medical Microbiology PSEUDOMONAS BRUCELLA LEGIONELLA CAMPYLOBACTER HELICOBACTER PYLORI (H.PYLORI) Pseudomonas Pseudomonas aeruginosa, Burkholderia pseudomallei and Burkholderia
ÐÑÏÓÊÅÊËÇÌÅÍÅÓ ÎÅÍÏÃËÙÓÓÅÓ ÁÍÁÊÏÉÍÙÓÅÉÓ ÅËËÇÍÙÍ ÅÑÅÕÍÇÔÙÍ
ÐÑÏÓÊÅÊËÇÌÅÍÅÓ ÎÅÍÏÃËÙÓÓÅÓ ÁÍÁÊÏÉÍÙÓÅÉÓ ÅËËÇÍÙÍ ÅÑÅÕÍÇÔÙÍ 205 206 ÐÑÏÓÊÅÊËÇÌÅÍÅÓ ÎÅÍÏÃËÙÓÓÅÓ ÁÍÁÊÏÉÍÙÓÅÉÓ ÅËËÇÍÙÍ ÅÑÅÕÍÇÔÙÍ EPITHELIAL CELL TURNOVER IN NON-DYSPLASTIC GASTRIC MUCOSA ADJACENT TO EARLY AND
H.pylori IgA Cat #
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external
Update on the pathological classification of gastritis. Hala El-Zimaity, M.D. M.S. Epidemiology McMaster University Hamilton, Ontario Canada
Update on the pathological classification of gastritis Hala El-Zimaity, M.D. M.S. Epidemiology McMaster University Hamilton, Ontario Canada CLASSIFICATION GASTRITIS GASTROPATHY 1. Acute 2. Chronic 3. Uncommon
RESEARCH COMMUNICATION. Comparison of Helicobacter pylori Antibody Detection in Stool with other Diagnostic Tests for Infection
Comparison of Helicobacter pylori Antibody Detection in Stool with other Diagnostic Tests RESEARCH COMMUNICATION Comparison of Helicobacter pylori Antibody Detection in Stool with other Diagnostic Tests
MEDICAL POLICY EFFECTIVE DATE: 05/19/11 REVISED DATE: 05/24/12, 05/23/13 ARCHIVED DATE: 05/22/14 EDITED DATE: 05/28/15, 05/25/16, 05/18/17, 05/17/18
MEDICAL POLICY SUBJECT: NON-INVASIVE HELICOBACTER PAGE: 1 OF: 6 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including
H.Pylori IgM Cat # 1504Z
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external
IgE levels are increased in patients with Helicobacter pylori infection
International Journal of Research in Applied and Basic Medical Sciences 2015; 1(1):51-55 IgE levels are increased in patients with Helicobacter pylori infection Rasmi Y 1, Hasani R 2, Sayyadi H 3, Sadreddini
C-Reactive Protein and Your Heart
C-Reactive Protein and Your Heart By: James L. Holly, MD Inflammation is the process by which the body responds to injury. Laboratory evidence and findings at autopsy studies suggest that the inflammatory
Functional dyspepsia: relationship between clinical subgroups and Helicobacter pylori status in Western Turkey
Brazilian Journal of Medical and Biological Research (2003) 36: 747-751 Dyspepsia and Helicobacter pylori ISSN 0100-879X 747 Functional dyspepsia: relationship between clinical subgroups and Helicobacter
The Usefulness of Sepsis Biomarkers. Dr Vineya Rai Department of Anesthesiology University of Malaya
The Usefulness of Sepsis Biomarkers Dr Vineya Rai Department of Anesthesiology University of Malaya 1 What is Sepsis? Whole Body Inflammatory State + Infection 2 Incidence and Burden of Sepsis in US In
Fluorescence immunoassay Point of care test Wide range PCT. whole blood. plasma. serum
Fluorescence immunoassay Point of care test Wide range PCT whole blood serum plasma ichroma PCT Description ichroma PCT along with ichroma Reader is a fluorescence immunoassay for quantitative determination
THE PREVALENCE OF HELICBACTER PYLORI AMONG PATIENTS COMPLAINING FROM ABDOMINAL PAIN
THE PREVALENCE OF HELICBACTER PYLORI AMONG PATIENTS COMPLAINING FROM ABDOMINAL PAIN Ahed J. Al-Khatib Jordan University of Science and Technology, Jordan Ahmed Saber Abu-zaiton Al-albayt University Abstract
Journal of Medical Science & Technology
Journal of Medical Science & Technology Original Article Helicobacter Pylori Colonization in Patients with Chronic Renal Failure K. Sunil Naik 1, S.vijaya 2 Baswaraj Munge 3 Open Access 1 Assistant professor,
Research Article Correlation between the Intensity of Helicobacter pylori Colonization and Severity of Gastritis
Hindawi Gastroenterology Research and Practice Volume 2017, Article ID 8320496, 5 pages https://doi.org/10.1155/2017/8320496 Research Article Correlation between the Intensity of Helicobacter pylori Colonization
Treatment of Helicobacter pylori Infection
Treatment of Helicobacter pylori Infection Epidemiology of H. pylori infection (North America) Which are the high risk groups? Epidemiology of H. pylori infection (North America) Which are the high risk
Cyclooxygenase-2 Expression in Gastric Antral Mucosa Before and After Eradication of Helicobacter pylori Infection
THE AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 94, No. 5, 1999 1999 by Am. Coll. of Gastroenterology ISSN 0002-9270/99/$20.00 Published by Elsevier Science Inc. PII S0002-9270(99)00126-4 Cyclooxygenase-2
H. pylori Stool Rapid Test (Cassette)
H. pylori Stool Rapid Test (Cassette) Cat. No.:DTS590 Pkg.Size: Intended use The H. pylori Stool Cassette is an immunochromatographic screening assay for the qualitative detectionof Helicobacter pylori
Sequioa Education Systems, Inc. 1
Functional Diagnostic Medicine Training Program Module 2 The Functional Diagnostic Medicine Approach in the Treatment of Gastrointestinal Dysfunction and Disease Dr. Wayne L. Sodano, D.C., D.A.B.C.I. &
JJBS Jordan Journal of Biological Sciences
JJBS Jordan Journal of Biological Sciences Volume 4, Number 2, June 2011 ISSN 1995-6673 Pages 71-76 Prevalence of Helicobacter Pylori Gastritis at the North of Jordan N. M. Abu-Ahmad, A. Odeh and A-K.
Correlation between Gastric Mucosal Morphologic Patterns and Histopathological Severity of
Hindawi Publishing Corporation BioMed Research International Volume 2015, Article ID 808505, 7 pages http://dx.doi.org/10.1155/2015/808505 Research Article Correlation between Gastric Mucosal Morphologic
American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection
American Journal of Gastroenterology ISSN 0002-9270 C 2007 by Am. Coll. of Gastroenterology doi: 10.1111/j.1572-0241.2007.01393.x Published by Blackwell Publishing American College of Gastroenterology
California Association for Medical Laboratory Technology
California Association for Medical Laboratory Technology Distance Learning Program A BACTERIAL CARCINOGEN HELICOBACTER PYLORI Course # DL by Lucy Treagan, Ph.D. Prof. Biol. Emerita University of San Francisco
Use of procalcitonin assay to streamline antibiotic usage. Dr Kristine Luk
Use of procalcitonin assay to streamline antibiotic usage Dr Kristine Luk Outline Procalcitonin physiology & kinetics Limitations Different settings - primary care & AED - critically ill patients - neutropenic
Factors modulating the outcome of treatment for the eradication of Helicobacter pylori infection
NEW MICROBIOLOGICA, 35, 335-340, 2012 Factors modulating the outcome of treatment for the eradication of Helicobacter pylori infection Natale Figura 1, Elena Moretti 2, L. Vaglio 1, F. Langone 1, Remo
Magaji et al., Afr. J. Infect. Dis. 2(2): THE ROLE OF AN AGGRESSIVE FACTOR IN PEPTIC ULCER DISEASE (PUD)
Magaji et al., Afr. J. Infect. Dis. 2(2): 80-84 80 Review Paper ISSN: 2006-0165 2008 THE ROLE OF AN AGGRESSIVE FACTOR IN PEPTIC ULCER DISEASE (PUD) Magaji, R.A. 1,b *, Tanko, Y. 2 and Magaji, G.M. 3 Afr.
EDUCATION PRACTICE. Persistent Helicobacter pylori Infection After a Course of Antimicrobial Therapy What s Next? Clinical Scenario.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2008;6:1086 1090 EDUCATION PRACTICE Persistent Helicobacter pylori Infection After a Course of Antimicrobial Therapy What s Next? RICHARD J. SAAD* and WILLIAM D.
Campylobacter. Helicobacter. Arcobacter 10/14/2011. General. Difference from Vibrio. Difference from Vibrio. Vibrio. Campylobacter
Helicobacter Gram-negative Short, curved (comma shaped), spiral or S forms May turn coccoid in old cultures Oxidase + Urease negative cf. Helicobacter mostly urease positive Microaerophilic (3% - 15% O
National Digestive Diseases Information Clearinghouse
Gastritis National Digestive Diseases Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What is gastritis? Gastritis is a condition in which the stomach
PCT. PCT in Bacterial Infections and Sepsis. Early Diagnosis. Assessment of Severity and Prognosis. Support for Therapeutic Decision Making
PCT PCT in Bacterial Infections and Sepsis Early Diagnosis Assessment of Severity and Prognosis Support for Therapeutic Decision Making Diagnosis and monitoring of sepsis Clinical need for earlier detection
THE IMPORTANCE OF DETERMINING PROCALCITONIN AND C REACTIVE PROTEIN IN DIFFERENT STAGES OF SEPSIS
& THE IMPORTANCE OF DETERMINING PROCALCITONIN AND C REACTIVE PROTEIN IN DIFFERENT STAGES OF SEPSIS Zana Baruti-Gafurri 1 *, Hidajet Paçarizi 1, Bukurije Zhubi 2, Luljeta Begolli 1, Valdete Topçiu 1 1 Institute
Rapid-VIDITEST. Helicobacter pylori. One step Helicobacter pylori Blister test. Instruction manual
Rapid-VIDITEST Helicobacter pylori One step Helicobacter pylori Blister test. Instruction manual Producer: VIDIA spol. s r.o., Nad Safinou II 365, 252 50 Vestec, Czech Republic, Tel.: +420 261 090 565,
The significance of Helicobacter pylori in the approach of dyspepsia in primary care Arents, Nicolaas Lodevikus Augustinus
University of Groningen The significance of Helicobacter pylori in the approach of dyspepsia in primary care Arents, Nicolaas Lodevikus Augustinus IMPORTANT NOTE: You are advised to consult the publisher's
Low Dose Furazolidone for Eradication of H- pylori Instead of Clarithromycin: A Clinical Trial
Global Journal of Health Science; Vol. 7, No. 1; 2015 ISSN 1916-9736 E-ISSN 1916-9744 Published by Canadian Center of Science and Education Low Dose Furazolidone for Eradication of H- pylori Instead of
Intragastric Acidification Reduces the Occurrence of False-Negative Urea Breath Test Results in Patients Taking a Proton Pump Inhibitor
THE AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 96, No. 4, 2001 2001 by Am. Coll. of Gastroenterology ISSN 0002-9270/01/$20.00 Published by Elsevier Science Inc. PII S0002-9270(01)02250-X Intragastric Acidification
Management of H. pylori Resistance
Management of H. pylori Resistance Manfred Kist, Erik Glocker, Nicole Wüppenhorst, Beate Hobmaier National Reference Centre for Helicobacter pylori Institute of Medical Microbiology and Hygiene Freiburg,
Prevalence of Helicobacter pylori in Patients with End Stage Renal Disease
2000;20:97-102 Helicobacter pylori Prevalence of Helicobacter pylori in Patients with End Stage Renal Disease Do Ha Kim, M.D., Hwoon-Yong Jung, M.D., Suk-Kyun Yang, M.D. Weon-Seon Hong, M.D. and Young
SUMMARY INTRODUCTION. Accepted for publication 25 May 2005
Aliment Pharmacol Ther 2005; 22: 243 249. doi: 10.1111/j.1365-2036.2005.02554.x Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated
A bleeding ulcer: What can the GP do? Gastrointestinal bleeding is a relatively common. How is UGI bleeding manifested? Who is at risk?
Focus on CME at the University of British Columbia A bleeding ulcer: What can the GP do? By Robert Enns, MD, FRCP Gastrointestinal bleeding is a relatively common disorder affecting thousands of Canadians
ETIOPATHOGENICAL ASPECTS OF NONSTEROIDAL ANTI- INFLAMMATORY DRUGS IN ELDERLY Mihaela Bursova¹, Gabriela Lilios², Maria Suta³, Gh.
ETIOPATHOGENICAL ASPECTS OF NONSTEROIDAL ANTI- INFLAMMATORY DRUGS IN ELDERLY Mihaela Bursova¹, Gabriela Lilios², Maria Suta³, Gh. Taralunga² 1.CLINICAL EMERGENCY COUNTY HOSPITAL CONSTANŢA, GERIATRICS DEPARTAMENT
Original Article. Abstract
Original Article Comparison of the C14 urea breath test and histopathology in the diagnosis of helicobacter pylori in the elderly Teslime Atli, 1 Sevnaz Sahin, 2 Bilge Ugur Arslan, 3 Murat Varli, 4 Ahmet